Bray Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.82M | Hold |
7,545
| – | – | 1.58% | 16 |
|
|
2024
Q3 | $6.68M | Hold |
7,545
| – | – | 1.64% | 14 |
|
|
2024
Q2 | $6.83M | Hold |
7,545
| – | – | 1.71% | 14 |
|
|
2024
Q1 | $5.87M | Hold |
7,545
| – | – | 1.49% | 15 |
|
|
2023
Q4 | $4.4M | Hold |
7,545
| – | – | 1.22% | 23 |
|
|
2023
Q3 | $4.05M | Hold |
7,545
| – | – | 1.23% | 25 |
|
|
2023
Q2 | $3.54M | Hold |
7,545
| – | – | 1.06% | 27 |
|
|
2023
Q1 | $2.59M | Hold |
7,545
| – | – | 0.76% | 39 |
|
|
2022
Q4 | $2.76M | Hold |
7,545
| – | – | 0.86% | 36 |
|
|
2022
Q3 | $2.44M | Hold |
7,545
| – | – | 0.76% | 41 |
|
|
2022
Q2 | $2.45M | Hold |
7,545
| – | – | 0.73% | 42 |
|
|
2022
Q1 | $2.16M | Hold |
7,545
| – | – | 0.56% | 53 |
|
|
2021
Q4 | $2.08M | Hold |
7,545
| – | – | 0.51% | 53 |
|
|
2021
Q3 | $1.74M | Hold |
7,545
| – | – | 0.45% | 59 |
|
|
2021
Q2 | $1.73M | Hold |
7,545
| – | – | 0.44% | 60 |
|
|
2021
Q1 | $1.41M | Buy |
7,545
+45
| +0.6% | +$8.8K | 0.39% | 69 |
|
|
2020
Q4 | $1.27M | Hold |
7,500
| – | – | 0.37% | 68 |
|
|
2020
Q3 | $1.11M | Hold |
7,500
| – | – | 0.39% | 63 |
|
|
2020
Q2 | $1.23M | Hold |
7,500
| – | – | 0.47% | 59 |
|
|
2020
Q1 | $1.04M | Hold |
7,500
| – | – | 0.48% | 57 |
|
|
2019
Q4 | $986K | Hold |
7,500
| – | – | 0.35% | 69 |
|
|
2019
Q3 | $839K | Sell |
7,500
-1,000
| -12% | -$111K | 0.33% | 72 |
|
|
2019
Q2 | $942K | Hold |
8,500
| – | – | 0.36% | 71 |
|
|
2019
Q1 | $1.1M | Hold |
8,500
| – | – | 0.46% | 59 |
|
|
2018
Q4 | $984K | Hold |
8,500
| – | – | 0.49% | 56 |
|
|
2018
Q3 | $912K | Hold |
8,500
| – | – | 0.4% | 60 |
|
|
2018
Q2 | $725K | Hold |
8,500
| – | – | 0.34% | 67 |
|
|
2018
Q1 | $658K | Sell |
8,500
-1,482
| -15% | -$119K | 0.31% | 67 |
|
|
2017
Q4 | $843K | Hold |
9,982
| – | – | 0.4% | 62 |
|
|
2017
Q3 | $854K | Sell |
9,982
-50
| -0.5% | -$4.1K | 0.45% | 58 |
|
|
2017
Q2 | $826K | Hold |
10,032
| – | – | 0.45% | 58 |
|
|
2017
Q1 | $844K | Hold |
10,032
| – | – | 0.48% | 58 |
|
|
2016
Q4 | $738K | Sell |
10,032
-6,018
| -37% | -$448K | 0.44% | 62 |
|
|
2016
Q3 | $1.29M | Buy |
16,050
+40
| +0.2% | +$3.2K | 0.78% | 52 |
|
|
2016
Q2 | $1.26M | Buy |
16,010
+1,945
| +14% | +$146K | 0.78% | 51 |
|
|
2016
Q1 | $1.01M | Sell |
14,065
-3,600
| -20% | -$272K | 0.88% | 42 |
|
|
2015
Q4 | $1.49M | Hold |
17,665
| – | – | 0.94% | 43 |
|
|
2015
Q3 | $1.48M | Sell |
17,665
-150
| -0.8% | -$12.7K | 0.94% | 39 |
|
|
2015
Q2 | $1.49M | Sell |
17,815
-750
| -4% | -$57.1K | 0.85% | 40 |
|
|
2015
Q1 | $1.35M | Sell |
18,565
-1,500
| -7% | -$107K | 0.8% | 49 |
|
|
2014
Q4 | $1.38M | Buy |
+20,065
| New | +$1.35M | 0.9% | 43 |
|
Other funds holding LLY
Bray Capital Advisors's LLY Position: Q4 2024 in Review
Bray Capital Advisors held its Eli Lilly (LLY) position steady in Q4 2024 at 7,545 shares worth $5.82M. The position accounts for 1.58% of the portfolio, ranked #16.
Bray Capital Advisors first reported a position in LLY in Q4 2014 and has held it in 41 quarters since. The position peaked at $6.83M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Bray Capital Advisors held 7,545 shares of Eli Lilly worth $5.82M as of Q4 2024.
- Bray Capital Advisors left its Eli Lilly share count unchanged in Q4 2024.
- Eli Lilly made up 1.58% of Bray Capital Advisors's portfolio in Q4 2024, its #16 holding.
- Bray Capital Advisors first reported a position in Eli Lilly in Q4 2014 and has held it in 41 quarters since.
- Bray Capital Advisors's Eli Lilly position peaked at $6.83M in Q2 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.